Valuation: Solventum Corporation

Market Cap 14.61B 13.26B 12.25B 11.05B 20.86B 1,365B 21.66B 148B 58.38B 736B 54.81B 53.65B 2,327B P/E 2026 *
75.6x
P/E 2027 * 20.1x
Enterprise Value 19.59B 17.78B 16.43B 14.82B 27.97B 1,830B 29.04B 198B 78.28B 987B 73.49B 71.94B 3,120B EV / Sales 2026 *
2.37x
EV / Sales 2027 * 2.21x
Free-Float
81.79%
Yield 2026 *
-
Yield 2027 * -
1 day-2.92%
1 week-4.83%
Current month+5.82%
1 month+0.29%
3 months-2.86%
6 months+15.89%
Current year+8.61%
1 week 86.03
Extreme 86.03
90.26
1 month 80.76
Extreme 80.76
93.1
Current year 62.38
Extreme 62.38
94.16
1 year 62.38
Extreme 62.38
94.16
3 years 47.16
Extreme 47.16
96.05
5 years 47.16
Extreme 47.16
96.05
10 years 47.16
Extreme 47.16
96.05
Date Insider Type Main position Quantity % Market Cap. Importance
9/1/26 A Exercice

Chief Executive Officer

160,990 0.0930%
8/17/26 A Free

Controller/Auditor

6,911 0.0040%
5/15/26 A Free

Director

3,300 0.0019%
Change 5-day change 1-year change 3-year change Capi.($)
-2.92%-4.83%+13.75% - 15.05B
-2.55%-5.25%-19.82%+4.44% 186B
-0.54%-0.46%+6.73%+36.65% 126B
+2.19%-2.51%-12.34%+8.91% 118B
-3.09%-6.19%-43.93%+0.52% 93.33B
-1.79%+1.39%-3.14%+78.03% 68.11B
-0.49%+0.08%+11.59%-8.36% 58.96B
-1.49%-2.32%+0.04%+47.92% 55.2B
+0.82%-0.21%-1.90%+38.56% 48.58B
-0.55%+0.95%+0.16%-0.74% 35.56B
Average -1.04%-0.27%-4.89%+22.88% 81B
Weighted average by Cap. -1.03%-0.96%-9.70%+20.07%

Financials

2026 *2027 *
Net sales 8.25B 7.49B 6.92B 6.24B 11.78B 771B 12.23B 83.35B 32.97B 416B 30.95B 30.3B 1,314B 8.56B 7.77B 7.18B 6.48B 12.23B 800B 12.7B 86.51B 34.22B 432B 32.12B 31.45B 1,364B
Net income 200M 182M 168M 152M 286M 18.72B 297M 2.02B 801M 10.1B 752M 736M 31.91B 740M 672M 621M 560M 1.06B 69.14B 1.1B 7.48B 2.96B 37.31B 2.78B 2.72B 118B
Net Debt 4.98B 4.52B 4.18B 3.77B 7.11B 465B 7.38B 50.31B 19.9B 251B 18.68B 18.29B 793B 4.35B 3.95B 3.65B 3.29B 6.21B 406B 6.45B 43.94B 17.38B 219B 16.31B 15.97B 693B
Projected Income Statement - Annual - Solventum Corporation
Logo Solventum Corporation
Solventum Corporation specializes in the marketing of tools used in the medical field. Net sales break down by group of products as follows: - medical instruments and accessories (57.9%): for wound care, sterilization, surgery, etc.; - medical information systems (16.3%): primarily software solutions for documentation, billing, coding, data visualization, etc. in hospital settings; - dental and orthodontic instruments and accessories (16.2%): for dental care and restoration; - purification and filtration instruments (6%): used in the medical, bio-pharmaceutical, agri-food and other sectors; - other (3.6%). The United States accounts for 56.1% of net sales.
Employees
20,584
Date Price Change Volume
17/11/26 $86.06 -2.92% 724,487
16/11/26 $88.65 -0.48% 848,112
13/11/26 $89.08 +0.30% 917,957
12/11/26 $88.81 +0.21% 1,014,516
11/11/26 $88.62 -1.62% 728,320
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Solventum Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
86.06USD
Average target price
98.38USD
Spread / Average Target
+14.32%
  1. Stock Market
  2. Stocks
  3. SOLV Stock